Calendar of Events
M Mon
T Tue
W Wed
T Thu
F Fri
S Sat
S Sun
0 events,
3 events,
Nasal Formulation & Delivery Summit
With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics. Whether for nose-to-brain delivery or emergency use, nasal delivery is opening a new era of more efficient drug and vaccine administration with life-saving potential. However, challenges in biologics formulation, along with renewed interest from major pharmaceutical companies […]
2nd Peptide-Based Therapeutics Summit
The 2nd Peptide-Based Therapeutics Summit will return to Boston in April 2025, bringing together over 80 experts in peptide computational science, medicinal chemistry, and formulation to discuss the latest advancements shaping the next generation of peptide-based therapies—from early-stage discovery to clinical application. Download the three-day program here: https://ter.li/rrvg1v This year’s summit will highlight groundbreaking innovations […]
6th TCR-Based Therapies Summit
Returning as the only event created selectively for and by the TCR community, the 6th TCR-based Therapies Summit (April 1-3, 2025 | Boston, MA) is your unique opportunity to connect and collaborate with TCR developers and experts to battle the specific discovery, preclinical and clinical challenges created by T cell receptor biology to advance cell- […]
0 events,
0 events,
0 events,
0 events,
1 event,
15th World Clinical Biomarkers & Companion Diagnostics Summit Europe
As recent advances in small molecules, ADCs, cell, and gene therapies poise novel precision therapies from the bench to the clinic, the 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe returns as the industry-leading end-to-end forum for Europe’s precision medicine community. Over three days, 170+ key stakeholders from across Europe working in Biomarkers, Translational […]
2 events,
Tumour Models Summit Nordics
Welcome to the first ever Tumour Models Summit Nordics. This April, the critically acclaimed Tumour Models series will be coming to the Nordics for the first time ever, uniting more than seventy pharma, biotech, and research leaders across the Nordic biotech landscape. The inherent heterogeneity of cancer - both inter-patient and intra-tumoral – remains a significant challenge in cancer modelling. With only 5% of cancer drugs successfully advancing to clinical trials, there is […]
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
1 event,
LEAP HR: Life Sciences West
LEAP HR: Life Sciences West is your chance to explore how leading and emerging biopharma organizations are navigating industry volatility and preparing for the workforce of tomorrow. As the sector recovers from funding challenges and workforce reductions, discover innovative ways to align your HR strategy with evolving business needs in 2025 and beyond. Join 200+ […]
1 event,
1 event,
0 events,
0 events,
0 events,
1 event,
4th ADC Analytical Development Summit
Unlock the Future of ADC Analytics at the 4th ADC Analytical Development Summit! When: April 2025 Where: Boston The 4th ADC Analytical Development Summit is back, bringing together top minds and innovators to tackle the unique analytical challenges of antibody-drug conjugates. With ADCs becoming more complex and regulatory requirements tightening, this event will be your ultimate guide to mastering […]
3 events,
2nd GLP-1-Based Therapeutics Summit
The 2nd GLP-1-Based Therapeutics Summit is an exclusive gateway to competitive intelligence into the continued potential of cutting-edge GLP-1s for obesity, weight loss, diabetes, and beyond. Join us to hear the latest clinical data on combination therapies to enhance muscle preservation, indication expansion into new areas, and strategies to improve the efficacy, tolerability, and durability of GLP-1s. With […]
2nd Measuring Patient Engagement Summit
As the healthcare industry evolves, patient engagement has become a crucial factor in shaping clinical trials, accelerating regulatory approvals, and improving the overall patient experience. Yet, amidst a challenging funding environment, empowered patients rightfully demanding greater involvement in treatment decisions, and regulatory bodies requiring transparent reporting of patient engagement activities, it has become more critical […]